Dedicare AB (publ) financials

Dedicare AB (publ)

Country: SE Reporting currency: SEK Latest annual report: 2024-12-31
LEI: 549300F01ELNT82H4P50
Source filing ↗
Financial statements (SEK, as reported — unscaled; 85 line items across 2 annual periods)
Line item 20242023
Income statement
Revenue SEK 1.74BSEK 1.99B
Other income SEK 15.8MSEK 21.3M
Employee benefits expense SEK 1.17BSEK 1.22B
Depreciation & amortisation SEK 24.6MSEK 24.4M
Operating profit (EBIT) SEK 60.2MSEK 148.4M
Finance costs SEK 12.9MSEK 21.4M
Profit before tax SEK 59.7MSEK 139.9M
Income tax expense SEK 12.6MSEK 29.5M
Profit for the year SEK 47.1MSEK 110.4M
— attributable to owners SEK 51.5MSEK 104.8M
Total comprehensive income SEK 51.5MSEK 104.8M
Cash flow statement
Net cash from operating activities SEK 81.3MSEK 145.4M
Income taxes paid SEK 28.3MSEK 40.6M
Net cash from investing activities -SEK 39.5M-SEK 9.7M
Purchase of PP&E (capex) SEK 191.0KSEK 2.1M
Purchase of intangibles SEK 3.1MSEK 2.5M
Net cash from financing activities -SEK 88.2M-SEK 81.8M
Repayments of borrowings SEK 13.8MSEK 13.7M
Lease liability payments SEK 12.2MSEK 10.4M
Net change in cash -SEK 46.4MSEK 53.9M
Balance sheet
Total assets SEK 628.8MSEK 727.3M
Non-current assets SEK 202.9MSEK 194.7M
Right-of-use assets SEK 22.7MSEK 21.5M
Intangible assets & goodwill SEK 163.9MSEK 165.2M
Current assets SEK 425.9MSEK 532.6M
Trade & other receivables SEK 164.5MSEK 194.5M
Cash & equivalents SEK 138.6MSEK 187.1M
Total equity SEK 299.3MSEK 309.9M
Non-current liabilities SEK 24.5MSEK 45.7M
Lease liabilities (non-current) SEK 11.1MSEK 8.1M
Current liabilities SEK 304.9MSEK 371.7M
Lease liabilities (current) SEK 11.2MSEK 12.0M
Deferred tax liabilities SEK 12.6MSEK 12.0M
Derived metrics
Free cash flow SEK 81.1MSEK 143.3M
Operating margin 3.5%7.4%
Net margin 2.7%5.5%
Return on equity 15.7%35.6%
Cash conversion ratio 1.73×1.32×
Capex coverage 425.57×69.80×
Other reported items
Accruals Classified As Current SEK 194.0MSEK 205.4M
Additional Paidin Capital SEK 28.6MSEK 28.6M
Adjustments For Decrease Increase In Other Operating Receivables SEK 19.6MSEK 10.7M
Adjustments For Decrease Increase In Trade Account Receivable SEK 29.3MSEK 26.2M
Adjustments For Increase Decrease In Other Operating Payables -SEK 23.6MSEK 2.0M
Adjustments For Increase Decrease In Trade Account Payable SEK 3.8M-SEK 10.0M
Basic Earnings Loss Per Share From Continuing Operations SEK 4.92SEK 11.55
Cash Flows From Used In Operations Before Changes In Working Capital SEK 52.2MSEK 116.4M
Changes In Inventories of Finished Goods and Work In Progress -SEK 3.1M-SEK 2.1M
Current Loans Received and Current Portion of Noncurrent Loans Received SEK 15.8MSEK 45.4M
Current Tax Assets Current SEK 7.0MSEK 13.1M
Current Tax Liabilities Current SEK 17.3MSEK 30.8M
Deferred Tax Assets SEK 9.5MSEK 424.0K
Diluted Earnings Loss Per Share From Continuing Operations SEK 4.89SEK 11.44
Dividends Paid To Equity Holders of Parent Classified As Financing Activities SEK 62.2MSEK 57.4M
Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners SEK 23.9MSEK 62.2M
Dividends Proposed Or Declared Before Financial Statements Authorised For Issue But Not Recognised As Distribution To Owners Per Share SEK 2.50SEK 6.50
Dividends Recognised As Distributions To Owners of Parent SEK 62.2MSEK 57.4M
Effect of Exchange Rate Changes On Cash and Cash Equivalents -SEK 2.2M-SEK 9.5M
Equity and Liabilities SEK 628.8MSEK 727.3M
Finance Income SEK 12.3MSEK 13.0M
Gains Losses On Exchange Differences On Translation Net of Tax SEK 4.5M-SEK 5.6M
Increase Decrease Through Transactions With Owners -SEK 62.2M-SEK 57.4M
Interest Paid Classified As Operating Activities SEK 2.9MSEK 3.6M
Interest Received Classified As Operating Activities SEK 6.6MSEK 4.7M
Issued Capital SEK 4.8MSEK 4.8M
Noncurrent Financial Assets At Amortised Cost SEK 5.1MSEK 5.0M
Noncurrent Portion of Noncurrent Loans Received SEK 0SEK 22.5M
Noncurrent Provisions SEK 817.0KSEK 3.1M
Office Equipment SEK 1.6MSEK 2.6M
Other Adjustments For Noncash Items SEK 16.2MSEK 13.0M
Other Adjustments To Reconcile Profit Loss SEK 277.0K-SEK 5.4M
Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax SEK 4.5M-SEK 5.6M
Other Current Liabilities SEK 58.1MSEK 72.1M
Other Current Receivables SEK 2.5MSEK 1.7M
Other Expense By Nature SEK 196.0MSEK 200.0M
Other Inflows Outflows of Cash Classified As Financing Activities -SEK 64.0K-SEK 243.0K
Payments For Share Issue Costs SEK 0SEK 56.0K
Prepayments and Accrued Income Including Contract Assets SEK 113.4MSEK 136.1M
Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities SEK 7.0KSEK 0
Professional Fees Expense SEK 283.0MSEK 396.8M
Reserve of Exchange Differences On Translation -SEK 6.1M-SEK 10.6M
Retained Earnings SEK 272.0MSEK 287.1M
Revenue From Rendering of Services SEK 1.72BSEK 1.97B
Share Issue Related Cost SEK 0SEK 57.0K
Trade and Other Current Payables To Trade Suppliers SEK 8.5MSEK 6.0M
Methodology

Every line item above is a fact tagged in Dedicare AB (publ)'s annual report filed in the European Single Electronic Format (ESEF) under the IFRS taxonomy (ifrs-full) — the income statement, balance sheet and cash-flow statement as the filer reported them. Values are shown as-is, in the reporting currency (SEK), without rescaling; the row labels map to the underlying concept name (e.g. Revenue → ifrs-full:Revenue, Operating profit → ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS → ifrs-full:DilutedEarningsLossPerShare), and any concept without a curated label is shown under “Other reported items” with its de-camel-cased tag name. Only consolidated, default-member facts are shown (segment / dimensional breakdowns are excluded).

“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.

Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.